Kane Biotech Inc.

Kane Biotech is a Canadian biotechnology company specializing in the research, development, and commercialization of technologies and products aimed at preventing and removing microbial biofilms. Their core focus is on developing innovative solutions that disrupt the formation of biofilms, which are sticky, protective layers of bacteria that can cause a range of infections and health problems. With a portfolio of 68 patents and patents pending, Kane Biotech is a leader in biofilm research and has a strong track record of developing effective anti-biofilm compounds.

The company operates through two primary commercialization vehicles: Kane Wound Care & Surgical and Kane Dermatology. Kane Wound Care & Surgical focuses on developing and commercializing products for the prevention and management of biofilm in chronic wounds, while Kane Dermatology targets the development of non-prescription consumables for end-consumers to address minor health ailments related to biofilm formation. These products are designed to be premium, non-antibiotic, and safe for human use, providing effective solutions for a variety of health concerns.

Kane Biotech is a Canadian biotechnology company dedicated to improving human and animal welfare through the research and development of innovative solutions to combat microbial biofilms and antimicrobial resistance. Their mission is to discover, develop, and commercialize technologies that effectively address the biofilm problem, ultimately improving the quality of life for individuals and animals alike.

Kane Biotech promotes a culture of innovation and collaboration, fostered by its location in the University of Manitoba Smartpark Innovation Hub. The company values hard work, talent, and a drive to contribute to their high-performing team. They are focused on developing technologies that address the global issue of biofilm, and offer opportunities for employees to work in a dynamic and exciting biotech environment.